Home › Mga Sakit sa Dugo
Pag-aaral pangklinika para sa Mga Sakit sa Dugo na nagre-recruit sa U.S.
36 pag-aaral para sa Mga Sakit sa Dugo ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX11 pag-aaral
- Atlanta, GA11 pag-aaral
- Boston, MA10 pag-aaral
- Los Angeles, CA10 pag-aaral
- New York City, NY9 pag-aaral
- The Bronx, NY8 pag-aaral
- Durham, NC7 pag-aaral
- Nashville, TN7 pag-aaral
- Mountain View, CA7 pag-aaral
- San Diego, CA6 pag-aaral
- Seattle, WA6 pag-aaral
- Indianapolis, IN5 pag-aaral
- Portland, OR5 pag-aaral
- Washington, DC5 pag-aaral
- Greenville, NC5 pag-aaral
- Columbus, OH4 pag-aaral
- Miami, FL4 pag-aaral
- Milwaukee, WI4 pag-aaral
- Tampa, FL4 pag-aaral
- Philadelphia, PA4 pag-aaral
- Cleveland, OH4 pag-aaral
- Baldwin Park, CA4 pag-aaral
- Birmingham, AL4 pag-aaral
- St. Louis, MO3 pag-aaral
- Augusta, GA3 pag-aaral
- Phoenix, AZ3 pag-aaral
- Orange, CA3 pag-aaral
- Buffalo, NY3 pag-aaral
- Clifton, NJ3 pag-aaral
- Sacramento, CA3 pag-aaral
- Cedar Rapids, IA3 pag-aaral
- Baltimore, MD3 pag-aaral
- Kansas City, MO3 pag-aaral
- San Francisco, CA3 pag-aaral
- Norfolk, VA3 pag-aaral
- Louisville, KY3 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona3 pag-aaral
- Arkansas3 pag-aaral
- California19 pag-aaral
- District of Columbia4 pag-aaral
- Florida10 pag-aaral
- Georgia13 pag-aaral
- Indiana5 pag-aaral
- Iowa3 pag-aaral
- Kentucky4 pag-aaral
- Maryland5 pag-aaral
- Massachusetts10 pag-aaral
- Minnesota4 pag-aaral
- Missouri5 pag-aaral
- New Jersey5 pag-aaral
- New York14 pag-aaral
- North Carolina11 pag-aaral
- Ohio7 pag-aaral
- Oregon5 pag-aaral
- Pennsylvania4 pag-aaral
- Tennessee7 pag-aaral
- Texas12 pag-aaral
- Virginia6 pag-aaral
- Washington7 pag-aaral
- Wisconsin5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia
Nagre-recruitPhase 3
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07935356A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06439082Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07601425A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06722235A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07712562Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Nagre-recruitPhase 3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07504458A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06948318Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults
Nagre-recruitPhase 1
3 Months – 25 Years · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT04806347HEME Home Transfusion Program
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06487247A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07059000Therapeutic RSK1 Targeting in Myeloid Malignancies
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07379125Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT05423691Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06828796A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT04256317Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06910969Treatment of Hemophilia A Patients With FVIII Inhibitors
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Kalalakihan · Na-update Set 23, 2026 · NCT04023019(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07075185ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05254743Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07216443Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Nagre-recruit
Hanggang edad 55 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01666080ATHNdataset Registry
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 21, 2026 · NCT06820515Diamond Blackfan Anemia Registry (DBAR)
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT00106015Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 pataas · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT03207854Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.